McDonald K M, Yoshiyama M, Francis G S, Ugurbil K, Cohn J N, Zhang J
Department of Medicine, University of Minnesota, Minneapolis.
J Am Coll Cardiol. 1994 Mar 1;23(3):786-93. doi: 10.1016/0735-1097(94)90769-2.
The purpose of this study was to assess high energy phosphate compound metabolism in remodeled left ventricular myocardium.
The development of heart failure several years after myocardial infarction is often unexplained. Certain abnormalities of remodeled myocardium suggest that structural changes occurring in viable myocardium after discrete myocardial damage may contribute to the later appearance of heart failure. Whether these abnormalities alter metabolism in the surviving muscle and thereby possibly contribute to ventricular dysfunction is unknown.
High energy phosphate compound metabolism was assessed using spatially localized phosphorus-31 nuclear magnetic resonance spectroscopy. Eleven dogs with documented left ventricular dysfunction, resulting from infarction produced by transmyocardial direct current shock, were compared with eight normal dogs. Analyses were performed at baseline and during coronary hyperperfusion induced by intravenous adenosine. Myocardial blood flow was measured with radioactive microspheres.
The creatine phosphate/adenosine triphosphate (CP/ATP) ratio was significantly reduced in the left ventricular dysfunction group in both the subepicardium ([mean +/- SE] 1.94 +/- 0.08 vs. 2.32 +/- 0.13, p = 0.019) and the subendocardium (1.71 +/- 0.07 vs. 2.05 +/- 0.07, p = 0.004). Intravenous adenosine produced significant coronary hyperemia in both groups but was less marked in dogs with left ventricular dysfunction. The improvement in myocardial perfusion was accompanied by a significant increase in the subendocardial CP/ATP ratio (from 1.71 +/- 0.07 to 1.92 +/- 0.08, p = 0.01) in dogs with left ventricular dysfunction.
An abnormal transmural distribution of high energy phosphate compounds is evident in remodeled myocardium. This abnormality may be related in part to mismatch of oxygen delivery and demand.
本研究旨在评估重构的左心室心肌中的高能磷酸化合物代谢。
心肌梗死后数年发生的心衰往往原因不明。重构心肌的某些异常表明,离散性心肌损伤后存活心肌中发生的结构变化可能导致心衰的后期出现。这些异常是否会改变存活心肌中的代谢,进而可能导致心室功能障碍尚不清楚。
使用空间定位的磷-31核磁共振波谱评估高能磷酸化合物代谢。将11只因经心肌直流电休克导致梗死而有左心室功能障碍记录的犬与8只正常犬进行比较。在基线和静脉注射腺苷诱导的冠状动脉高灌注期间进行分析。用放射性微球测量心肌血流量。
左心室功能障碍组的心外膜下([均值±标准误]1.94±0.08对2.32±0.13,p = 0.019)和心内膜下(1.71±0.07对2.05±0.07,p = 0.004)磷酸肌酸/三磷酸腺苷(CP/ATP)比值均显著降低。静脉注射腺苷在两组中均产生了显著的冠状动脉充血,但在左心室功能障碍的犬中不太明显。左心室功能障碍的犬心肌灌注改善伴随着心内膜下CP/ATP比值显著增加(从1.71±0.07增至1.92±0.08,p = 0.01)。
高能磷酸化合物的跨壁分布异常在重构心肌中明显。这种异常可能部分与氧输送和需求不匹配有关。